[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global mRNA Drug Market Research Report 2024(Status and Outlook)

July 2024 | 113 pages | ID: G2F76BCC7A39EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview:

Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.

The Global mRNA Drug Market Size was estimated at USD 410.83 million in 2023 and is projected to reach USD 550.55 million by 2029, exhibiting a CAGR of 5.00% during the forecast period.

This report provides a deep insight into the global mRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global mRNA Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mRNA Drug market in any manner.

Global mRNA Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Moderna

Pfizer

Zydus Cadila

Fosun Pharma

CureVAC

Sri Lankan Microorganisms

BioNtech

AstraZeneca

Janssen

Market Segmentation (by Type)

Preventive Vaccines

Therapeutic Vaccine

Therapeutic Drugs

Market Segmentation (by Application)

Hospital

Clinic

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the mRNA Drug Market
  • Overview of the regional outlook of the mRNA Drug Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the mRNA Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of mRNA Drug
1.2 Key Market Segments
  1.2.1 mRNA Drug Segment by Type
  1.2.2 mRNA Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MRNA DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global mRNA Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global mRNA Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MRNA DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Global mRNA Drug Sales by Manufacturers (2019-2024)
3.2 Global mRNA Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 mRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global mRNA Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers mRNA Drug Sales Sites, Area Served, Product Type
3.6 mRNA Drug Market Competitive Situation and Trends
  3.6.1 mRNA Drug Market Concentration Rate
  3.6.2 Global 5 and 10 Largest mRNA Drug Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 MRNA DRUG INDUSTRY CHAIN ANALYSIS

4.1 mRNA Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MRNA DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 MRNA DRUG MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global mRNA Drug Sales Market Share by Type (2019-2024)
6.3 Global mRNA Drug Market Size Market Share by Type (2019-2024)
6.4 Global mRNA Drug Price by Type (2019-2024)

7 MRNA DRUG MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global mRNA Drug Market Sales by Application (2019-2024)
7.3 Global mRNA Drug Market Size (M USD) by Application (2019-2024)
7.4 Global mRNA Drug Sales Growth Rate by Application (2019-2024)

8 MRNA DRUG MARKET SEGMENTATION BY REGION

8.1 Global mRNA Drug Sales by Region
  8.1.1 Global mRNA Drug Sales by Region
  8.1.2 Global mRNA Drug Sales Market Share by Region
8.2 North America
  8.2.1 North America mRNA Drug Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe mRNA Drug Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific mRNA Drug Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America mRNA Drug Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa mRNA Drug Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Moderna
  9.1.1 Moderna mRNA Drug Basic Information
  9.1.2 Moderna mRNA Drug Product Overview
  9.1.3 Moderna mRNA Drug Product Market Performance
  9.1.4 Moderna Business Overview
  9.1.5 Moderna mRNA Drug SWOT Analysis
  9.1.6 Moderna Recent Developments
9.2 Pfizer
  9.2.1 Pfizer mRNA Drug Basic Information
  9.2.2 Pfizer mRNA Drug Product Overview
  9.2.3 Pfizer mRNA Drug Product Market Performance
  9.2.4 Pfizer Business Overview
  9.2.5 Pfizer mRNA Drug SWOT Analysis
  9.2.6 Pfizer Recent Developments
9.3 Zydus Cadila
  9.3.1 Zydus Cadila mRNA Drug Basic Information
  9.3.2 Zydus Cadila mRNA Drug Product Overview
  9.3.3 Zydus Cadila mRNA Drug Product Market Performance
  9.3.4 Zydus Cadila mRNA Drug SWOT Analysis
  9.3.5 Zydus Cadila Business Overview
  9.3.6 Zydus Cadila Recent Developments
9.4 Fosun Pharma
  9.4.1 Fosun Pharma mRNA Drug Basic Information
  9.4.2 Fosun Pharma mRNA Drug Product Overview
  9.4.3 Fosun Pharma mRNA Drug Product Market Performance
  9.4.4 Fosun Pharma Business Overview
  9.4.5 Fosun Pharma Recent Developments
9.5 CureVAC
  9.5.1 CureVAC mRNA Drug Basic Information
  9.5.2 CureVAC mRNA Drug Product Overview
  9.5.3 CureVAC mRNA Drug Product Market Performance
  9.5.4 CureVAC Business Overview
  9.5.5 CureVAC Recent Developments
9.6 Sri Lankan Microorganisms
  9.6.1 Sri Lankan Microorganisms mRNA Drug Basic Information
  9.6.2 Sri Lankan Microorganisms mRNA Drug Product Overview
  9.6.3 Sri Lankan Microorganisms mRNA Drug Product Market Performance
  9.6.4 Sri Lankan Microorganisms Business Overview
  9.6.5 Sri Lankan Microorganisms Recent Developments
9.7 BioNtech
  9.7.1 BioNtech mRNA Drug Basic Information
  9.7.2 BioNtech mRNA Drug Product Overview
  9.7.3 BioNtech mRNA Drug Product Market Performance
  9.7.4 BioNtech Business Overview
  9.7.5 BioNtech Recent Developments
9.8 AstraZeneca
  9.8.1 AstraZeneca mRNA Drug Basic Information
  9.8.2 AstraZeneca mRNA Drug Product Overview
  9.8.3 AstraZeneca mRNA Drug Product Market Performance
  9.8.4 AstraZeneca Business Overview
  9.8.5 AstraZeneca Recent Developments
9.9 Janssen
  9.9.1 Janssen mRNA Drug Basic Information
  9.9.2 Janssen mRNA Drug Product Overview
  9.9.3 Janssen mRNA Drug Product Market Performance
  9.9.4 Janssen Business Overview
  9.9.5 Janssen Recent Developments

10 MRNA DRUG MARKET FORECAST BY REGION

10.1 Global mRNA Drug Market Size Forecast
10.2 Global mRNA Drug Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe mRNA Drug Market Size Forecast by Country
  10.2.3 Asia Pacific mRNA Drug Market Size Forecast by Region
  10.2.4 South America mRNA Drug Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of mRNA Drug by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global mRNA Drug Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of mRNA Drug by Type (2025-2030)
  11.1.2 Global mRNA Drug Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of mRNA Drug by Type (2025-2030)
11.2 Global mRNA Drug Market Forecast by Application (2025-2030)
  11.2.1 Global mRNA Drug Sales (Kilotons) Forecast by Application
  11.2.2 Global mRNA Drug Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. mRNA Drug Market Size Comparison by Region (M USD)
Table 5. Global mRNA Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global mRNA Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global mRNA Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global mRNA Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Drug as of 2022)
Table 10. Global Market mRNA Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers mRNA Drug Sales Sites and Area Served
Table 12. Manufacturers mRNA Drug Product Type
Table 13. Global mRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of mRNA Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. mRNA Drug Market Challenges
Table 22. Global mRNA Drug Sales by Type (Kilotons)
Table 23. Global mRNA Drug Market Size by Type (M USD)
Table 24. Global mRNA Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global mRNA Drug Sales Market Share by Type (2019-2024)
Table 26. Global mRNA Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global mRNA Drug Market Size Share by Type (2019-2024)
Table 28. Global mRNA Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global mRNA Drug Sales (Kilotons) by Application
Table 30. Global mRNA Drug Market Size by Application
Table 31. Global mRNA Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global mRNA Drug Sales Market Share by Application (2019-2024)
Table 33. Global mRNA Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global mRNA Drug Market Share by Application (2019-2024)
Table 35. Global mRNA Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global mRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global mRNA Drug Sales Market Share by Region (2019-2024)
Table 38. North America mRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe mRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific mRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America mRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa mRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Moderna mRNA Drug Basic Information
Table 44. Moderna mRNA Drug Product Overview
Table 45. Moderna mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Moderna Business Overview
Table 47. Moderna mRNA Drug SWOT Analysis
Table 48. Moderna Recent Developments
Table 49. Pfizer mRNA Drug Basic Information
Table 50. Pfizer mRNA Drug Product Overview
Table 51. Pfizer mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Pfizer Business Overview
Table 53. Pfizer mRNA Drug SWOT Analysis
Table 54. Pfizer Recent Developments
Table 55. Zydus Cadila mRNA Drug Basic Information
Table 56. Zydus Cadila mRNA Drug Product Overview
Table 57. Zydus Cadila mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Zydus Cadila mRNA Drug SWOT Analysis
Table 59. Zydus Cadila Business Overview
Table 60. Zydus Cadila Recent Developments
Table 61. Fosun Pharma mRNA Drug Basic Information
Table 62. Fosun Pharma mRNA Drug Product Overview
Table 63. Fosun Pharma mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Fosun Pharma Business Overview
Table 65. Fosun Pharma Recent Developments
Table 66. CureVAC mRNA Drug Basic Information
Table 67. CureVAC mRNA Drug Product Overview
Table 68. CureVAC mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CureVAC Business Overview
Table 70. CureVAC Recent Developments
Table 71. Sri Lankan Microorganisms mRNA Drug Basic Information
Table 72. Sri Lankan Microorganisms mRNA Drug Product Overview
Table 73. Sri Lankan Microorganisms mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sri Lankan Microorganisms Business Overview
Table 75. Sri Lankan Microorganisms Recent Developments
Table 76. BioNtech mRNA Drug Basic Information
Table 77. BioNtech mRNA Drug Product Overview
Table 78. BioNtech mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BioNtech Business Overview
Table 80. BioNtech Recent Developments
Table 81. AstraZeneca mRNA Drug Basic Information
Table 82. AstraZeneca mRNA Drug Product Overview
Table 83. AstraZeneca mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AstraZeneca Business Overview
Table 85. AstraZeneca Recent Developments
Table 86. Janssen mRNA Drug Basic Information
Table 87. Janssen mRNA Drug Product Overview
Table 88. Janssen mRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Janssen Business Overview
Table 90. Janssen Recent Developments
Table 91. Global mRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global mRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America mRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America mRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe mRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe mRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific mRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific mRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America mRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America mRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa mRNA Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa mRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global mRNA Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global mRNA Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global mRNA Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global mRNA Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global mRNA Drug Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of mRNA Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global mRNA Drug Market Size (M USD), 2019-2030
Figure 5. Global mRNA Drug Market Size (M USD) (2019-2030)
Figure 6. Global mRNA Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. mRNA Drug Market Size by Country (M USD)
Figure 11. mRNA Drug Sales Share by Manufacturers in 2023
Figure 12. Global mRNA Drug Revenue Share by Manufacturers in 2023
Figure 13. mRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market mRNA Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by mRNA Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global mRNA Drug Market Share by Type
Figure 18. Sales Market Share of mRNA Drug by Type (2019-2024)
Figure 19. Sales Market Share of mRNA Drug by Type in 2023
Figure 20. Market Size Share of mRNA Drug by Type (2019-2024)
Figure 21. Market Size Market Share of mRNA Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global mRNA Drug Market Share by Application
Figure 24. Global mRNA Drug Sales Market Share by Application (2019-2024)
Figure 25. Global mRNA Drug Sales Market Share by Application in 2023
Figure 26. Global mRNA Drug Market Share by Application (2019-2024)
Figure 27. Global mRNA Drug Market Share by Application in 2023
Figure 28. Global mRNA Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global mRNA Drug Sales Market Share by Region (2019-2024)
Figure 30. North America mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America mRNA Drug Sales Market Share by Country in 2023
Figure 32. U.S. mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada mRNA Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico mRNA Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe mRNA Drug Sales Market Share by Country in 2023
Figure 37. Germany mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific mRNA Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific mRNA Drug Sales Market Share by Region in 2023
Figure 44. China mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America mRNA Drug Sales and Growth Rate (Kilotons)
Figure 50. South America mRNA Drug Sales Market Share by Country in 2023
Figure 51. Brazil mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa mRNA Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa mRNA Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa mRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global mRNA Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global mRNA Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global mRNA Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global mRNA Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global mRNA Drug Sales Forecast by Application (2025-2030)
Figure 66. Global mRNA Drug Market Share Forecast by Application (2025-2030)


More Publications